Ambu A/S (OTCMKTS:AMBBY – Get Free Report)’s share price rose 5.3% during trading on Thursday . The company traded as high as $17.57 and last traded at $17.57. Approximately 200 shares traded hands during trading, a decline of 47% from the average daily volume of 380 shares. The stock had previously closed at $16.69.
Ambu A/S Stock Performance
The stock has a market cap of $4.13 billion and a PE ratio of 103.35. The business has a 50-day moving average of $18.35 and a 200 day moving average of $17.70. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.47 and a current ratio of 2.60.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.10 EPS for the quarter. Ambu A/S had a return on equity of 5.67% and a net margin of 5.69%.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Recommended Stories
- Five stocks we like better than Ambu A/S
- What Are Dividend Champions? How to Invest in the Champions
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What is Put Option Volume?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
